{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:47:42Z","timestamp":1793173662493,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.radonc.2023.109640","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T11:17:11Z","timestamp":1679915831000},"page":"109640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG)"],"prefix":"10.1016","volume":"183","author":[{"given":"Nobuteru","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Suefuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisaku","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyako","family":"Satouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruhiko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Shioyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109640_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2023.109640_b0010","unstructured":"Cancer Information Service National Cancer Center, Japan. Annual Report of Hospital-Based Cancer Registries. https:\/\/jhcr-cs.ganjoho.jp\/hbcrtables\/ [accessed 19 November 2022]."},{"key":"10.1016\/j.radonc.2023.109640_b0015","unstructured":"Clinical N, Guidelines P, Guidelines N. NCCN Clinical Practice Guidelines in Oncology, Non-Small Cell Lung Cancer 2021. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/nscl.pdf [accessed 25 June 2021]."},{"key":"10.1016\/j.radonc.2023.109640_b0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","article-title":"Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403","volume":"93","author":"Nagata","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109640_b0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ijrobp.2006.10.006","article-title":"Curative treatment of Stage I non-small-cell lung cancer with carbon ion beams using a hypofractionated regimen","volume":"67","author":"Miyamoto","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109640_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13010112","article-title":"Long term results of single-fraction carbon-ion radiotherapy for non-small cell lung cancer","volume":"13","author":"Ono","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.109640_b0035","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1002\/cam4.2561","article-title":"Hypofractionated carbon-ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): prospective phase II study","volume":"8","author":"Saitoh","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2023.109640_b0040","series-title":"TNM Classification of Malignant Tumours","author":"James","year":"2016"},{"key":"10.1016\/j.radonc.2023.109640_b0045","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 Published: November 27, 2017. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf [accessed 7 November 2022]."},{"key":"10.1016\/j.radonc.2023.109640_b0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(98)00544-6","article-title":"Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy","volume":"44","author":"Kanai","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109640_b0055","doi-asserted-by":"crossref","first-page":"e1096","DOI":"10.1002\/mp.12506","article-title":"Radiobiological issues in prospective carbon ion therapy trials","volume":"45","author":"Fossati","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.109640_b0060","unstructured":"R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/. n.d."},{"key":"10.1016\/j.radonc.2023.109640_b0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/jrr\/rrw057","article-title":"Carbon-ion pencil beam scanning for thoracic treatment - Initiation report and dose metrics evaluation","volume":"57","author":"Karube","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2023.109640_b0070","doi-asserted-by":"crossref","unstructured":"Miyasaka Y, Komatsu S, Abe T, Kubo N, Okano N, Shibuya K, et al. Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13. https:\/\/doi.org\/10.3390\/cancers13020176.","DOI":"10.3390\/cancers13020176"},{"key":"10.1016\/j.radonc.2023.109640_b0075","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.3892\/ol.2017.5952","article-title":"Maximum standardized uptake value on FDG-PET predicts survival in stage i non-small cell lung cancer following carbon ion radiotherapy","volume":"13","author":"Shirai","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.radonc.2023.109640_b0080","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.3747\/co.23.3051","article-title":"Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes on outcomes in lung stereotactic body radiotherapy","volume":"23","author":"Giuliani","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2023.109640_b0085","first-page":"1","article-title":"Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer","author":"Matsuo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109640_b0090","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/JTO.0b013e318074de34","article-title":"Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study","volume":"2","author":"Onishi","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109640_b0095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.lungcan.2018.12.022","article-title":"Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma","volume":"128","author":"Abel","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2023.109640_b0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lungcan.2014.02.015","article-title":"Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study","volume":"84","author":"Ricardi","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2023.109640_b0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lungcan.2015.12.003","article-title":"Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer","volume":"92","author":"Tsurugai","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2023.109640_b0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1470-2045(18)30896-9","article-title":"Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial","volume":"20","author":"Ball","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109640_b0115","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.ijrobp.2009.07.1751","article-title":"Stereotactic body radiotherapy (SBRT) for operable Stage i non-small-cell lung cancer: Can SBRT be comparable to surgery?","volume":"81","author":"Onishi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109640_b0120","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jtcvs.2010.01.046","article-title":"Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)","volume":"140","author":"Dunlap","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.radonc.2023.109640_b0125","first-page":"885","article-title":"A phase I study of hypofractionated carbon-ion radiotherapy for stage III Non-small cell lung cancer","volume":"38","author":"Saitoh","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2023.109640_b0130","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.29195","article-title":"A prospective nonrandomized phase I\/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC)","volume":"121","author":"Takahashi","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109640_b0135","first-page":"5099","article-title":"Dosimetric analysis between carbon ion radiotherapy and stereotactic body radiotherapy in stage I lung cancer","volume":"34","author":"Ebara","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2023.109640_b0140","article-title":"Impact of interstitial changes on radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"35","author":"Yoshitake","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2023.109640_b0145","doi-asserted-by":"crossref","unstructured":"Glick D, Lyen S, Kandel S, Shapera S, Le LW, Lindsay P, et al. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT). Clin Lung Cancer n.d.;19:219\u201345. https:\/\/doi.org\/10.1016\/j.cllc.2017.06.021.","DOI":"10.1016\/j.cllc.2017.06.021"},{"key":"10.1016\/j.radonc.2023.109640_b0150","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/JTO.0000000000000359","article-title":"Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer","volume":"10","author":"Ueki","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2023.109640_b0155","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.3390\/cancers13164204","article-title":"Efficacy and safety of carbon-ion radiotherapy for stage I non-small cell lung cancer with coexisting interstitial lung disease","volume":"13","author":"Okano","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.109640_b0160","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(00)00524-1","article-title":"Respiratory gated irradiation system for heavy-ion radiotherapy","volume":"47","author":"Minohara","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109640_b0165","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12194-013-0208-3","article-title":"Technical approach to individualized respiratory-gated carbon-ion therapy for mobile organs","volume":"6","author":"Tashiro","year":"2013","journal-title":"Radiol Phys Technol"},{"key":"10.1016\/j.radonc.2023.109640_b0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13014-014-0238-y","article-title":"Carbon-ion scanning lung treatment planning with respiratory-gated phase-controlled rescanning: simulation study using 4-dimensional CT data","volume":"9","author":"Takahashi","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109640_b0175","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/acm2.13376","article-title":"Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: treatment planning","volume":"22","author":"Tsubouchi","year":"2021","journal-title":"J Appl Clin Med Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:30:11Z","timestamp":1759123811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023001780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":35,"alternative-id":["S0167814023001780"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109640","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical results of carbon ion radiotherapy for inoperable stage I non-small cell lung cancer: A Japanese national registry study (J-CROS-LUNG)","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109640"}}